A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations
NCT00116402
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
fluticasone and salmeterol
Sponsor
University of Chicago
Collaborators
[object Object]